Sepsis Diagnostics Market
Global Sepsis Diagnostics Market Size, Share & Trends Analysis Report by Product Type (Instruments, Assays & Reagents, and Others), By Technology (Molecular Diagnostics, Immunoassay, and Others), By Pathogen (Bacterial Sepsis Diagnostics, Fungal Sepsis Diagnostics, and Others), and Forecast 2019-2025
The global sepsis diagnostics market is anticipated to grow at a significant CAGR during the forecast period. Sepsis is amongst one of the severe diseases and emerges as a leading cause of fatality globally. It occurs when chemicals released in the bloodstream to fight an infection generates inflammation throughout the body. Some of the symptoms include fever, difficulty in breathing, low BP, rapid heart rate, and mental confusion. However, early diagnosis of the disease can enhance the conditions and even contributes to market growth.
The primary factors that propel the growth of the market include increased incidences of sepsis, the introduction of technologically advanced diagnostic solutions along with increased awareness among the peoples. As per WHO, sepsis is one of the life-threatening diseases, and it affects approximately 30 million people across the globe and causes around 6 million deaths every year. Every year approximately 1.2 million children and 3 million infants suffer from sepsis across the globe. Thus, the increased incidences of sepsis are likely to create scope for market growth during the forecast period.
Moreover, in the geriatric population, newborn babies, and people suffering from chronic disease, there are increased chances of hospital-acquired infections (HAIs) which may cause sepsis. AS per CDC, in the US alone, approximately 1.7 million patients suffer from HAIs, in which approximately 99,000 patients die due to HAIs. Thus, the increased incidences and prevalence of HAIs are also likely to propel the market growth during the forecast period.
In June 2018 Sepsis Alliance, a non-profit organization involved “It's About Time”, a nationwide initiative to create awareness regarding rapid diagnosis and treatment of the sepsis. Such initiatives by the organizations are intended to raise awareness about the disease and encourage the demand for its diagnostic solutions. Thus, it is estimated to create ample opportunities for the growth of the market.
Segmental Outlook
The global sepsis diagnostics market is sectioned into product type, technology, and pathogen. On the basis of product type, the market is segmented into instruments, assays & reagents, and others. Based on the technology, the market is segmented into molecular diagnostics, microbiology, immunoassay, and others including flow cytometry. Whereas, based on the pathogen, the market is segmented into bacterial sepsis diagnostics, fungal sepsis diagnostics, and others.
Molecular Diagnostics is Likely to Hold Significant Market Share
Amongst the technology segment of the global sepsis diagnostic market, molecular diagnostics segment holds a considerable share in the market. The segmental share is accredited to the fact that it enables the quantitative diagnosis of microorganisms by application of blood culture media tests. While molecular diagnostic offers various benefits such as précised results and high sensitivity in comparison with other technologies. Additionally, it is also considered as a standard pathogen identification technology followed by blood culture.
Regional Outlook
The global sepsis diagnostics market is geographically segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold a significant share in the global market during the forecast period. This is attributed to the footprints of the key companies focusing on the advent of technologically advanced tools and technologies for the early-stage detection and diagnosis of sepsis. Some of the global players operating in the region comprise F. Hoffmann-La Roche Ltd., Danaher Corp., Thermo Fisher Scientific Inc., Abbott Laboratories, Inc., Becton, Dickinson, & Co., and others. Companies are launching novel products, while some products have already received the US FDA clearance to be used for diagnosis purposes. Moreover, Europe is also considered as a significant region, accrediting to various R&D activities going on in the region. For instance, in February 2019, the University of Strathclyde in UK introduced a cost-friendly test for the detection of early-stage sepsis. The test kit utilizes microelectrode that analyses the patients’ blood and gives out final results in around two and a half minutes.
Global Sepsis Diagnostics Market by Region, 2018 (%)
Market Players Outlook
Some of the prominent players operating in the global sepsis diagnostics market include Abbott Laboratories, Inc., Becton, Dickinson & Co., Biomérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Luminex Corp., Qiagen NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc, among others. These are the key companies adopting several organic and inorganic growth strategies such as product launches & developments, partnerships, agreements, and acquisitions to strengthen their product portfolios and maintain a competitive position in the global sepsis diagnostics market.
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global sepsis diagnostics market. Based on the availability of data, information related to products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. bioMérieux SA
3.2.1.1. Overview
3.2.1.2. Financial Analysis
3.2.1.3. SWOT Analysis
3.2.1.4. Recent Developments
3.2.2. Becton, Dickinson, & Company
3.2.2.1. Overview
3.2.2.2. Financial Analysis
3.2.2.3. SWOT Analysis
3.2.2.4. Recent Developments
3.2.3. Thermo Fisher Scientific, Inc.
3.2.3.1. Overview
3.2.3.2. Financial Analysis
3.2.3.3. SWOT Analysis
3.2.3.4. Recent Developments
3.2.4. F. Hoffmann-La Roche Ltd.
3.2.4.1. Overview
3.2.4.2. Financial Analysis
3.2.4.3. SWOT Analysis
3.2.4.4. Recent Developments
3.2.5. Abbott Laboratories Inc.
3.2.5.1. Overview
3.2.5.2. Financial Analysis
3.2.5.3. SWOT Analysis
3.2.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Sepsis Diagnostics Market by Product Type
5.1.1. Instruments
5.1.2. Assays and Reagents
5.1.3. Others
5.2. Global Sepsis Diagnostics Market by Technology
5.2.1. Molecular Diagnostics
5.2.2. Immunoassay
5.2.3. Others (Flow Cytometry)
5.3. Global Sepsis Diagnostics Market by Pathogen
5.3.1. Bacterial Sepsis Diagnostics
5.3.2. Fungal Sepsis Diagnostics
5.3.3. Others
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Abionic SA
7.3. Accelerate Diagnostics, Inc.
7.4. Becton, Dickinson & Co.
7.5. Biomérieux SA
7.6. Bruker Corp.
7.7. Cepheid Inc.
7.8. Danaher Corp.
7.9. EKF Diagnostics Holdings plc
7.10. F. Hoffmann-La Roche Ltd.
7.11. Immunexpress Inc.
7.12. Inflammatix, Inc.
7.13. Luminex Corp.
7.14. Nan?mix, Inc.
7.15. Qiagen NV
7.16. Quidel Corp.
7.17. Seegene Inc.
7.18. Siemens AG
7.19. Sysmex Corp.
7.20. T2 Biosystems, Inc.
7.21. Thermo Fisher Scientific Inc.
7.22. Trinity Biotech Plc
1. GLOBAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
2. GLOBAL SEPSIS DIAGNOSTICS INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL SEPSIS DIAGNOSTICS ASSAYS AND REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL OTHER SEPSIS DIAGNOSTICS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
6. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL IMMUNOASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
8. GLOBAL OTHER TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
10. GLOBAL BACTERIAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL FUNGAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
12. GLOBAL OTHER PATHOGEN MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
14. NORTH AMERICAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
15. NORTH AMERICAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
16. NORTH AMERICAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
17. NORTH AMERICAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
18. EUROPEAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
19. EUROPEAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
20. EUROPEAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
21. EUROPEAN SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
22. ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
23. ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
24. ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
25. ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
26. REST OF THE WORLD SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
27. REST OF THE WORLD SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
28. REST OF THE WORLD SEPSIS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PATHOGEN, 2018-2025 ($ MILLION)
1. GLOBAL SEPSIS DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
2. GLOBAL SEPSIS DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
3. GLOBAL SEPSIS DIAGNOSTICS MARKET SHARE BY PATHOGEN, 2018 VS 2025 (%)
4. GLOBAL SEPSIS DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. US SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
6. CANADA SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
7. UK SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
8. FRANCE SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
9. GERMANY SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
10. ITALY SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
11. SPAIN SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
12. ROE SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
13. INDIA SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
14. CHINA SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
15. JAPAN SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
17. REST OF THE WORLD SEPSIS DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
